ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Micafungin Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-8T8511
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Micafungin Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Micafungin Drug Market Research Report 2025

Code: QYRE-Auto-8T8511
Report
July 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astellas
Endo International
Xellia Pharmaceuticals
TEVA
Hikma
Jiangsu Hansoh Pharmaceutical
Apotex

Micafungin Drug Market Size

The global market for Micafungin Drug was valued at US$ 722 million in the year 2024 and is projected to reach a revised size of US$ 1079 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Micafungin Drug Market

Micafungin Drug Market

Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Micafungin Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Micafungin Drug.
The Micafungin Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Micafungin Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Micafungin Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Micafungin Drug Market Report

Report Metric Details
Report Name Micafungin Drug Market
Accounted market size in year US$ 722 million
Forecasted market size in 2031 US$ 1079 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 50 mg Single-use Vial
  • 100 mg Single-use Vial
Segment by Application
  • Candidemia
  • Respiratory Mycosis
  • Gastrointestinal Mycosis
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Astellas, Endo International, Xellia Pharmaceuticals, Teva, Hikma, Jiangsu Hansoh Pharmaceutical, Apotex
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Micafungin Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Micafungin Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Micafungin Drug Market growing?

Ans: The Micafungin Drug Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Micafungin Drug Market size in 2031?

Ans: The Micafungin Drug Market size in 2031 will be US$ 1079 million.

Who are the main players in the Micafungin Drug Market report?

Ans: The main players in the Micafungin Drug Market are Astellas, Endo International, Xellia Pharmaceuticals, Teva, Hikma, Jiangsu Hansoh Pharmaceutical, Apotex

What are the Application segmentation covered in the Micafungin Drug Market report?

Ans: The Applications covered in the Micafungin Drug Market report are Candidemia, Respiratory Mycosis, Gastrointestinal Mycosis

What are the Type segmentation covered in the Micafungin Drug Market report?

Ans: The Types covered in the Micafungin Drug Market report are 50 mg Single-use Vial, 100 mg Single-use Vial

Recommended Reports

Fungal And Infective

Rare And Chronic

Sleep And Neurology

1 Micafungin Drug Market Overview
1.1 Product Definition
1.2 Micafungin Drug by Type
1.2.1 Global Micafungin Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 50 mg Single-use Vial
1.2.3 100 mg Single-use Vial
1.3 Micafungin Drug by Application
1.3.1 Global Micafungin Drug Market Value by Application (2024 VS 2031)
1.3.2 Candidemia
1.3.3 Respiratory Mycosis
1.3.4 Gastrointestinal Mycosis
1.4 Global Micafungin Drug Market Size Estimates and Forecasts
1.4.1 Global Micafungin Drug Revenue 2020-2031
1.4.2 Global Micafungin Drug Sales 2020-2031
1.4.3 Global Micafungin Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Micafungin Drug Market Competition by Manufacturers
2.1 Global Micafungin Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Micafungin Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Micafungin Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Micafungin Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Micafungin Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Micafungin Drug, Product Type & Application
2.7 Global Key Manufacturers of Micafungin Drug, Date of Enter into This Industry
2.8 Global Micafungin Drug Market Competitive Situation and Trends
2.8.1 Global Micafungin Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Micafungin Drug Players Market Share by Revenue
2.8.3 Global Micafungin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Micafungin Drug Market Scenario by Region
3.1 Global Micafungin Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Micafungin Drug Sales by Region: 2020-2031
3.2.1 Global Micafungin Drug Sales by Region: 2020-2025
3.2.2 Global Micafungin Drug Sales by Region: 2026-2031
3.3 Global Micafungin Drug Revenue by Region: 2020-2031
3.3.1 Global Micafungin Drug Revenue by Region: 2020-2025
3.3.2 Global Micafungin Drug Revenue by Region: 2026-2031
3.4 North America Micafungin Drug Market Facts & Figures by Country
3.4.1 North America Micafungin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Micafungin Drug Sales by Country (2020-2031)
3.4.3 North America Micafungin Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Micafungin Drug Market Facts & Figures by Country
3.5.1 Europe Micafungin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Micafungin Drug Sales by Country (2020-2031)
3.5.3 Europe Micafungin Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Micafungin Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Micafungin Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Micafungin Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Micafungin Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Micafungin Drug Market Facts & Figures by Country
3.7.1 Latin America Micafungin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Micafungin Drug Sales by Country (2020-2031)
3.7.3 Latin America Micafungin Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Micafungin Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Micafungin Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Micafungin Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Micafungin Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Micafungin Drug Sales by Type (2020-2031)
4.1.1 Global Micafungin Drug Sales by Type (2020-2025)
4.1.2 Global Micafungin Drug Sales by Type (2026-2031)
4.1.3 Global Micafungin Drug Sales Market Share by Type (2020-2031)
4.2 Global Micafungin Drug Revenue by Type (2020-2031)
4.2.1 Global Micafungin Drug Revenue by Type (2020-2025)
4.2.2 Global Micafungin Drug Revenue by Type (2026-2031)
4.2.3 Global Micafungin Drug Revenue Market Share by Type (2020-2031)
4.3 Global Micafungin Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Micafungin Drug Sales by Application (2020-2031)
5.1.1 Global Micafungin Drug Sales by Application (2020-2025)
5.1.2 Global Micafungin Drug Sales by Application (2026-2031)
5.1.3 Global Micafungin Drug Sales Market Share by Application (2020-2031)
5.2 Global Micafungin Drug Revenue by Application (2020-2031)
5.2.1 Global Micafungin Drug Revenue by Application (2020-2025)
5.2.2 Global Micafungin Drug Revenue by Application (2026-2031)
5.2.3 Global Micafungin Drug Revenue Market Share by Application (2020-2031)
5.3 Global Micafungin Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Astellas
6.1.1 Astellas Company Information
6.1.2 Astellas Description and Business Overview
6.1.3 Astellas Micafungin Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Astellas Micafungin Drug Product Portfolio
6.1.5 Astellas Recent Developments/Updates
6.2 Endo International
6.2.1 Endo International Company Information
6.2.2 Endo International Description and Business Overview
6.2.3 Endo International Micafungin Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Endo International Micafungin Drug Product Portfolio
6.2.5 Endo International Recent Developments/Updates
6.3 Xellia Pharmaceuticals
6.3.1 Xellia Pharmaceuticals Company Information
6.3.2 Xellia Pharmaceuticals Description and Business Overview
6.3.3 Xellia Pharmaceuticals Micafungin Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Xellia Pharmaceuticals Micafungin Drug Product Portfolio
6.3.5 Xellia Pharmaceuticals Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Micafungin Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Micafungin Drug Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Hikma
6.5.1 Hikma Company Information
6.5.2 Hikma Description and Business Overview
6.5.3 Hikma Micafungin Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hikma Micafungin Drug Product Portfolio
6.5.5 Hikma Recent Developments/Updates
6.6 Jiangsu Hansoh Pharmaceutical
6.6.1 Jiangsu Hansoh Pharmaceutical Company Information
6.6.2 Jiangsu Hansoh Pharmaceutical Description and Business Overview
6.6.3 Jiangsu Hansoh Pharmaceutical Micafungin Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Jiangsu Hansoh Pharmaceutical Micafungin Drug Product Portfolio
6.6.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
6.7 Apotex
6.7.1 Apotex Company Information
6.7.2 Apotex Description and Business Overview
6.7.3 Apotex Micafungin Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Apotex Micafungin Drug Product Portfolio
6.7.5 Apotex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Micafungin Drug Industry Chain Analysis
7.2 Micafungin Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Micafungin Drug Production Mode & Process Analysis
7.4 Micafungin Drug Sales and Marketing
7.4.1 Micafungin Drug Sales Channels
7.4.2 Micafungin Drug Distributors
7.5 Micafungin Drug Customer Analysis
8 Micafungin Drug Market Dynamics
8.1 Micafungin Drug Industry Trends
8.2 Micafungin Drug Market Drivers
8.3 Micafungin Drug Market Challenges
8.4 Micafungin Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astellas
Endo International
Xellia Pharmaceuticals
TEVA
Hikma
Jiangsu Hansoh Pharmaceutical
Apotex
List of Tables
 Table 1. Global Micafungin Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Micafungin Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Micafungin Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Micafungin Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Micafungin Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Micafungin Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Micafungin Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Micafungin Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Micafungin Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Micafungin Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Micafungin Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Micafungin Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Micafungin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Micafungin Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Micafungin Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Micafungin Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Micafungin Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Micafungin Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Micafungin Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Micafungin Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Micafungin Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Micafungin Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Micafungin Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Micafungin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Micafungin Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Micafungin Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Micafungin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Micafungin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Micafungin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Micafungin Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Micafungin Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Micafungin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Micafungin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Micafungin Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Micafungin Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Micafungin Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Micafungin Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Micafungin Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Micafungin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Micafungin Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Micafungin Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Micafungin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Micafungin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Micafungin Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Micafungin Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Micafungin Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Micafungin Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Micafungin Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Micafungin Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Micafungin Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Micafungin Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Micafungin Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Micafungin Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Micafungin Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Micafungin Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Micafungin Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Micafungin Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Micafungin Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Micafungin Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Micafungin Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Micafungin Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Micafungin Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Micafungin Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Micafungin Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Micafungin Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Micafungin Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Micafungin Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Micafungin Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. Astellas Company Information
 Table 71. Astellas Description and Business Overview
 Table 72. Astellas Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Astellas Micafungin Drug Product
 Table 74. Astellas Recent Developments/Updates
 Table 75. Endo International Company Information
 Table 76. Endo International Description and Business Overview
 Table 77. Endo International Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Endo International Micafungin Drug Product
 Table 79. Endo International Recent Developments/Updates
 Table 80. Xellia Pharmaceuticals Company Information
 Table 81. Xellia Pharmaceuticals Description and Business Overview
 Table 82. Xellia Pharmaceuticals Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Xellia Pharmaceuticals Micafungin Drug Product
 Table 84. Xellia Pharmaceuticals Recent Developments/Updates
 Table 85. Teva Company Information
 Table 86. Teva Description and Business Overview
 Table 87. Teva Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Teva Micafungin Drug Product
 Table 89. Teva Recent Developments/Updates
 Table 90. Hikma Company Information
 Table 91. Hikma Description and Business Overview
 Table 92. Hikma Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Hikma Micafungin Drug Product
 Table 94. Hikma Recent Developments/Updates
 Table 95. Jiangsu Hansoh Pharmaceutical Company Information
 Table 96. Jiangsu Hansoh Pharmaceutical Description and Business Overview
 Table 97. Jiangsu Hansoh Pharmaceutical Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Jiangsu Hansoh Pharmaceutical Micafungin Drug Product
 Table 99. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
 Table 100. Apotex Company Information
 Table 101. Apotex Description and Business Overview
 Table 102. Apotex Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Apotex Micafungin Drug Product
 Table 104. Apotex Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Micafungin Drug Distributors List
 Table 108. Micafungin Drug Customers List
 Table 109. Micafungin Drug Market Trends
 Table 110. Micafungin Drug Market Drivers
 Table 111. Micafungin Drug Market Challenges
 Table 112. Micafungin Drug Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Micafungin Drug
 Figure 2. Global Micafungin Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Micafungin Drug Market Share by Type: 2024 & 2031
 Figure 4. 50 mg Single-use Vial Product Picture
 Figure 5. 100 mg Single-use Vial Product Picture
 Figure 6. Global Micafungin Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Micafungin Drug Market Share by Application: 2024 & 2031
 Figure 8. Candidemia
 Figure 9. Respiratory Mycosis
 Figure 10. Gastrointestinal Mycosis
 Figure 11. Global Micafungin Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Micafungin Drug Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Micafungin Drug Sales (2020-2031) & (K Units)
 Figure 14. Global Micafungin Drug Average Price (US$/Unit) & (2020-2031)
 Figure 15. Micafungin Drug Report Years Considered
 Figure 16. Micafungin Drug Sales Share by Manufacturers in 2024
 Figure 17. Global Micafungin Drug Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Micafungin Drug Players: Market Share by Revenue in Micafungin Drug in 2024
 Figure 19. Micafungin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Micafungin Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Micafungin Drug Sales Market Share by Country (2020-2031)
 Figure 22. North America Micafungin Drug Revenue Market Share by Country (2020-2031)
 Figure 23. United States Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Micafungin Drug Sales Market Share by Country (2020-2031)
 Figure 26. Europe Micafungin Drug Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Micafungin Drug Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Micafungin Drug Revenue Market Share by Region (2020-2031)
 Figure 34. China Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Micafungin Drug Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Micafungin Drug Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Micafungin Drug Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Micafungin Drug Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Micafungin Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Micafungin Drug by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Micafungin Drug by Type (2020-2031)
 Figure 55. Global Micafungin Drug Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Micafungin Drug by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Micafungin Drug by Application (2020-2031)
 Figure 58. Global Micafungin Drug Price (US$/Unit) by Application (2020-2031)
 Figure 59. Micafungin Drug Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Micafungin Sodium Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Micafungin Sodium for Injection Market Insights Forecast to 2030
Micafungin Sodium Powder for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Echinocandins Market Research Report 2024
Micafungin Sodium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antifungal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vincamine Market Research Report 2025
Propiverine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Miconazole Market Research Report 2024
Global Echinocandins Antifungal Drugs Market Research Report 2024
5 Fluocytosine Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Topotecan Market Insights Forecast to 2030
Global Naftifine Hydrochloride Ointment Market Insights Forecast to 2030
Global Efinaconazole Market Insights Forecast to 2030
Global Antimycotic Medication Market Insights Forecast to 2030
Camylofin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Echinocandins for Injection Market Research Report 2024
Global Mucormycosis Treatment Drugs Market Research Report 2025
Ivermectin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Flecainide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions